EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Complexity of Soluble Checkpoint Molecules in Modulating Immune-Mediated Diseases and Autoimmunity

Elias Toubi, Raeda Mubariki, Zahava Vadasz

International Journal of Molecular Sciences · 16.08.2026 · 27 (16) · 7319

DOI: 10.3390/ijms27167319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.08.2026. Verfasst von Elias Toubi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel. Hauptthemen laut MEDLINE: Autoimmunity, Immune Checkpoint Proteins, Autoimmune Diseases, Immune System Diseases. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For many decades, the regulation of immune responses, namely, the maintenance of self-tolerance and the prevention of pro-inflammatory processes, was attributed to the suppressive function of T and/or B regulatory cells. However, the field of immune regulation was recently expanded to include not only many membrane-bound regulatory molecules on immune cells but also the release of many soluble molecules playing a role in the modulation of immune responses. Soluble checkpoint molecules are the subject of many recent studies, in which they were reported to function as both regulatory and stimulatory molecules. They are involved in the pathogenesis of immune-mediated disorders, infections, and cancer, and are involved in balancing immune effector responses with regulatory reactions. Many of them have become relevant targets in treating these diseases. In this review, we chose to focus on those soluble molecules whose role is attributed to immune-mediated diseases, namely in modulating autoimmunity by enhancing mechanisms of self-tolerance and immunosuppressive signals. The understanding of these mechanisms might facilitate the development of future therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityImmune Checkpoint ProteinsAutoimmune DiseasesImmune System DiseasesHumansAnimalsSelf Tolerance

Stichwörter der Autor:innen

autoimmunitymodulationsoluble checkpoint molecules

Substanzen

Immune Checkpoint Proteins

Autor:innen und Institutionen

  • Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.
  • The Proteomic Unit, Bnai-Zion Medical Center, Haifa 31048, Israel.

Zitieren

APA

Toubi, E., Mubariki, R., & Vadasz, Z. (2026). The Complexity of Soluble Checkpoint Molecules in Modulating Immune-Mediated Diseases and Autoimmunity. International Journal of Molecular Sciences, 27(16), 7319. https://doi.org/10.3390/ijms27167319

Vancouver

Toubi E, Mubariki R, Vadasz Z. The Complexity of Soluble Checkpoint Molecules in Modulating Immune-Mediated Diseases and Autoimmunity. International Journal of Molecular Sciences. 2026;27(16):7319. doi:10.3390/ijms27167319

BibTeX
@article{Toubi2026,
  author = {Toubi, Elias and Mubariki, Raeda and Vadasz, Zahava},
  title = {The Complexity of Soluble Checkpoint Molecules in Modulating Immune-Mediated Diseases and Autoimmunity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7319},
  doi = {10.3390/ijms27167319}
}
Kostenlos starten →